Stock Locations

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

1797832-75-7Acyclovir EP Impurity I

● In Stock

Catalogue No.:	VL13020
CAS No.:	1797832-75-7
Mol. Formula:	C14H16N10O4
Mol. Weight:	388.34 g/mol

Request a quote

Add to RFQ list

Additional information on CAS 1797832-75-7

Parent drug

Acyclovir

IUPAC Name

2-Amino-7-[[2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9- yl)methoxy]ethoxy] methyl]-1,7-dihydro-6H-purin-6-one

Pharmacopoeial Synonyms

N/A

Other Synonyms

Acyclovir 7,9 Diguanyl Analog; O-[(Guanin-7-yl)methyl] Acyclovir; O-[(Guanin-7-yl)methyl] Acyclovir; 7,9′-(ETHYLENEBIS(OXYMETHYLENE))DIGUANINE; (7,9′-(ETHYLENEBIS(OXYMETHYLENE))DIGUANINE); 2-Amino-9-((2-((2-amino-6-oxo-3,6-dihydro-7H-purin-7-yl)methoxy)ethoxy)methyl)-3,9-dihydro-6H-purin-6-one

Smiles

C1=NC2=C(N1COCCOCN3C=NC4=C3C(=O)NC(=N4)N)N=C(NC2=O)N

InChI

InChI=1S/C14H16N10O4/c15-13-19-9-8(12(26)22-13)23(4-18-9)5-27-1-2-28-6-24-3-17-7-10(24)20-14(16)21-11(7)25/h3-4H,1-2,5-6H2,(H3,15,19,22,26)(H3,16,20,21,25)

Description

Acyclovir EP Impurity I is a meticulously characterized reference material that complies with rigorous regulatory requirements, including those defined by USP, EMA, JP, and BP. This product plays a crucial role in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial manufacturing of Acyclovir. It is further supported by a detailed Structure Elucidation Report (SER), ensuring high accuracy and reliability across a broad range of analytical applications.

References

Huidobro, A. L., et al. â€œLC Methods for Acyclovir and Related Impurities Determination.â€ Journal of Pharmaceutical and Biomedical Analysis, vol. 37, no. 4, Apr. 2005, pp. 687â€“94, https://doi.org/10.1016/j.jpba.2004.11.039.